Ophthalmic Eye Drops Market
Market Insights on Ophthalmic Eye Drops covering sales outlook, demand forecast & up-to-date key trends
Ophthalmic Eye Drops Market by Drug Class (Anesthetic Drops, Dilation Drops, Glaucoma Drops, Steroid Drops, Antibiotic Drops, Others), Indication (Dry Eye, Eye Allergy, Glaucoma, Eye Infection), Drug Formulation, Container Type, Distribution Channel & Region - Forecast to 2020-2030
About the Report
Ophthalmic eye drops are used to deliver medications locally in the ocular cavities to treat ocular conditions or regain normal eye function. The most common and easiest route of ocular drug administration, representing the treatment of choice, is topical instillation of eye drops. The prevalence and incidence and eye infections is expected to rise globally. Emergence of new pathogens, increasing number of post-operative eye infections and poor eye hygiene are likely to boost the global ophthalmic eye drops market.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving the demand for ophthalmic eye drops. The report tracks the global sales of ophthalmic eye drops in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the pharmaceutical industry in general, and ophthalmic eye drops in particular.
Let us know your requirement to get
100% FREE customization
How does Historic and Future Outlook for Ophthalmic Eye Drops Market Compare?
One of the significant types of eye infection is post-operative ocular infection. This risk of infection is associated with various ocular surgical conditions which demand eye surgeries. Rising number of ocular surgical conditions has increased the demand for post-operative ocular anti-infective therapies. Ocular surgical conditions such as cataracts, glaucoma, age-related macular degeneration (AMD) and diabetic retinopathy are growing due to aging population and sedentary lifestyle habits. This is creating a huge opportunity for the ophthalmic eye drops market.
For instance, cataracts affect more than 24.4 million Americans aged 40 and older. By age 75, approximately half of all Americans have cataracts. Also, diabetic retinopathy affects nearly 7.7 million Americans aged 40 and older.
Similarly, in the United States, there were 48,229 corneal transplants performed in 2013. Since 1961, more than 1,000,000 men, women and children ranging in age from nine days to 100+ years, have had their sight restored through a corneal transplant.
According to FMI’s analysis, ophthalmic eye drops sales have grown from US$ 12.02 Bn in 2015 to US$14.17BMn in 2019.
The outbreak of COVID19 has disturbed many industries with lockdowns imposed after the outbreak. Industries and economies were affected by the mass spread of the infection, resulting in recession due to the closing down of the offices, factories and markets. As a result, the demand and supply of ophthalmic eye drops was halted, leading to a great loss to the growth of the ophthalmic eye drops market.
The global focus of research and development (R&D) shifted onto the development of the COVID-19 vaccine. As a result, the majority of the research funds and investments were channeled towards COVID-19 vaccine development. However, the ophthalmic eye drops demand is expected to grow from the current dip in the growth trend, with the reopening of the economies and markets.
FMI expects global ophthalmic eye drops demand to grow at 4.1% CAGR through 2030.
How will Initiatives in Creating Awareness Influence Ophthalmic Eye Drops Demand?
The World Health Organization (WHO) and international associations in the field of eye health are actively addressing the care for eye health and accelerating the awareness, diagnosis and treatment of several eye conditions, including eye infections.
For instance, VISION 2020 is a global initiative created by the International Agency for the Prevention of Blindness (IAPB) and the World Health Organization (WHO) in 1999 aimed at eliminating preventable or avoidable eye diseases by the year 2020. In order to reach this goal, VISION 2020 acts to facilitate the development and implementation of sustainable national eye-care programs based on three foundations: human resource development, cost-effective disease control, and infrastructure and technology, and principles of primary health care delivery.
The final objective of VISION 2020 is to integrate a sustainable, comprehensive, high-quality, and equitable eye care system into national health-care systems. In addition, in countries like India, surgeries of cataracts are mostly offered for free via various government programs in the country to the section that falls short of financial aid.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystHow will Technological Advancements Affect Ophthalmic Eye Drops Sales?
Eye infections can be caused by several pathogens, including bacteria, amoeba, viruses, and fungi. Bacterial and viral conjunctivitis are highly contagious and may result from a number of common agents, including adenovirus, rubella, herpes, staphylococcus aureus, measles, and streptococcus pneumoniae, among others.
Currently ~60% of patients in the U.S. are prescribed antibiotic eye drops, even though antibiotics are rarely necessary to treat common eye infections. Leading diagnostic industry players are focusing on development and commercialization of rapid point-of-care diagnostic technologies for eye infections. The rapid method is expected to boost the accurate use of anti-infective therapeutics.
For instance, AdenoPlus is a point?of?care diagnostic, a single use test for adenoviral conjunctivitis. The adenovirus serotypes contain a protein called hexon that is detected by AdenoPlus. The test takes around 10 minutes to return a result.
AdenoPlus test is a diagnostic device for acute conjunctivitis and an in vitro diagnostic medical device for which the manufacturer (Rapid Pathogen Screening) received a CE mark in June 2011. The current UK distributor is Nicox Pharma SNC. It is cheaper than the current gold standard PCR test, although PCR is not commonly used because the results are not available in time to guide first?line management.
How is Lack of Awareness Affecting Growth?
The blindness rates in wealthy countries are commonly below 0.5 percent, sometimes much lower. The rate of blindness in many poor countries exceeds 1–2 percent. Reduced acuity that can seriously impair personal functioning, including employment, is at least 6 times more common than blindness. As a result, roughly 30 million people, mostly in the poorer countries of the world, are (to a large degree unnecessarily) blind, and 200 million more are unable to participate fully in the workforce.
Cataracts account for 20 million blind people worldwide, but disproportionately, over 50% of blindness in developing countries. According to the WHO, in 2019, at least 2.2 billion people have vision impairment or blindness, of which over 1 billion cases could have been prevented or have yet to be addressed. Lack of awareness about disease diagnosis and treatment is likely to hamper the market growth.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Country-wise Insights
How Big is the Opportunity in the US?
In the U.S., the healthcare system is well known for its expenditure and advanced infrastructure. The care regime of the care centers and hospitals are covered by regulations and insurance policies. Government and regulatory bodies of the U.S. are adopting various cost-effective plans to reduce their healthcare burden.
Furthermore, due to the higher prevalence of bacterial and viral diseases, the demand for ophthalmic eye drops is increasing. Adenoviral conjunctivitis results in a large number of physician office visits in the United States and places a great financial burden on health care. It is recorded that the incidence of adenovirus infection is as high as 20 million cases per year in the United States. Nearly a million eye infections that require a trip to the doctor or hospital happen each year, many of them related to contact lens use.
The Centers for Disease Control and Prevention (CDC) reported that more than 2.8 million antibiotic-resistant infections occur in the U.S. each year. The government is putting in place prevention and infection control efforts in the U.S. to reduce the number of infections and deaths caused by antibiotic-resistant germs, but the number of people facing antibiotic resistance is still too high.
How is the Ophthalmic Eye Drops Market of Germany Flourishing?
The German healthcare system is a universal, multi-payer system that is largely funded by the government. It is one of the most successful healthcare systems in the world. It is not surprising that Germany has the highest level of spending in Europe. Furthermore, the presence of several key players, rising prevalence of eye infections, rising technological advancements, and growing R&D in the country creates a huge opportunity for the ophthalmic eye drops market to grow. The Germany ophthalmic eye drops market is expected to reach 982.6 Mn by the end of 2030.
What are the Factors Driving the India Ophthalmic Eye Drops Market?
Increasing investments in the healthcare sector in emerging countries, especially India, is anticipated to boost the demand for ocular infection therapeutics. Increasing promotional and awareness activities and improving healthcare access is expected to provide significant opportunities in the emerging regions for the ophthalmic eye drops market.
Category-wise Insights
Why do Dilation Eye Drops Dominate the Ophthalmic Eye Drops Market?
The demand for dilation eye drops is rising worldwide. Dilation eye drops are used on the majority of patients daily during surgical procedures and diagnostic examinations. They are extremely important in order to get an accurate view of the fundus and retina. Indeed, failure to perform in-depth diagnosis of the eye could cause significant harm to the patient such as failure to diagnose or delay in diagnosis, as well as surgical difficulties due to poor visibility. The dilation eye drops segment is likely to grow with a CAGR of 5.3%.
What is the Share of with Preservative in Drug Formulation?
With preservative segment dominated the ophthalmic eye drops market in revenue terms in 2020 and is projected to reach a market share of 89.2% by 2030 in the forecast period.
Why are Dry Eyes Considered Leading Indication Segment?
The rising prevalence of dry eyes condition makes it the dominant indication segment. Some experts estimated that dry eye affects millions of adults in the United States. The risk of developing dry eye increases with advancing age. Women have a higher prevalence of dry eye compared with men. Currently between 16 million and 49 million Americans have dry eyes. This is between 5-15% of the population.
Which Container Type to lead the Ophthalmic Eye Drops Market?
The adoption of multiple dose container is likely to grow, making it the leading and revenue generating container segment in the market. It is anticipated to grow at a CAGR of 3.8% during the forecast period.
What is the Revenue Share of Institutional Sales?
Institutional sales will continue to grow and dominate the ophthalmic eye drops market during the forecast period. According to FMI, the segment is expected to hold around 60.4% of the market share, in terms of distribution channel, by the end of 2030. Institutional sales hold dominance in terms of revenue owing to the higher flow of patients in hospitals, ophthalmic clinics, community clinics, and others.
Competitive Landscape
Strengthening partnerships with major distributors and long-term contracts with end users of ophthalmic eye drops are key strategies adopted by market players. A number of global players have entered into agreements and collaborations to strengthen their sales footprint, increase profitability and sustain market share as they face stiff competition from other major competitors.
Manufacturers are focusing on the development of customized products for end-use industries. They also have entered into long-term agreements with direct end-users.
Some of the leading companies operating in the ophthalmic eye drops market are:
- Novartis AG
- Bausch & Lomb
- Akorn, Inc.
- Biomedica
- AdvaCare Pharma
- C2 PHARMA
- Kraeber GmbH
- Iskon Remedies
- HANSHIN GROUP
- Berry Global Inc.
- Nolato AB
- Bormioli Pharma
- WG Pro-Manufacturing Inc.
- Gerresheimer AG
- Adelphi Healthcare Packaging
- Aptar Group Inc.
- Amcor Plc.
*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.
Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2020-2030 |
|
Historical Data Available for |
2015-2019 |
|
Market Analysis |
USD Million for Value and Mn Units for Volume |
|
Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa |
|
Key Countries Covered |
US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, and South Africa |
|
Key Segments Covered |
Drug Class, Indication, Drug Formulation, Container Type, Distribution Channel, and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Ophthalmic Eye Drops Market by Category
Drug Class
- Anesthetic Drops
- Dilation Drops
- Glaucoma Drops
- Steroid Drops
- Antibiotic Drops
- Others (Antihistamine, Lubricants Tear Drops)
Indication
- Dry Eye
- Eye Allergy
- Glaucoma
- Eye Infection
- Retinal Disorders
- Macular Degeneration
- Diabetic Retinopathy
- Others
- Uveitis
- Others
Drug Formulation
- With Preservative
- Preservative Free
Container Type
- Single Dose Container
- Multiple-Dose Container
Distribution Channel
- Institutional Sales
- Hospitals
- Community Clinics
- Ophthalmic Clinics
- Public Health Agencies
- Veterinary Hospitals & Clinics
- Retail Sales
- Retail Pharmacies
- Drug Stores
Region
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
Which is the most lucrative market for ophthalmic eye drops?
The U.S. currently leads the global market for ophthalmic eye drops. Sales in the U.S. will be around 29% of total global demand throughout the forecast period.
Which are the top-selling ophthalmic eye drops?
Dilation eye drops are dominating the drug class segment in the ophthalmic eye drops market as compared to other products owing to their high demand.
Which are some of the leading companies offering ophthalmic eye drops?
Some of the leading companies offering ophthalmic eye drops are Novartis AG, Bausch & Lomb, Akorn, Inc., Biomedica, AdvaCare Pharma, C2 PHARMA, Kraeber GmbH, Iskon Remedies, HANSHIN GROUP, Berry Global Inc., Nolato AB, Bormioli Pharma, WG Pro-Manufacturing Inc., Gerresheimer AG, Adelphi Healthcare Packaging, Aptar Group Inc., Acor Plc., and others.
Which distribution channel is driving revenue of ophthalmic eye drops?
Institutional sales is leading the distribution channel segment of the ophthalmic eye drops demand.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technology Roadmap 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Development Trends 4. Key Success Factors 4.1. Disease Epidemiology, By Regions 4.2. Regulatory & Reimbursement Landscape 4.3. Parent Market Overview 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Increasing Prevalence of Eye infections and disorders 5.2.2. Treatment Seeking Rate 5.2.3. Product launches 5.2.4. Product Cost 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Impact Analysis 6.1. Current COVID-19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as compared to 2008 financial analysis 6.4. COVID19 and Impact Analysis 6.5. 2020 Market Scenario 6.6. Recovery Scenario - Short term, Midterm and Long Term Impact 7. Global Ophthalmic Eye Drops Market Volume (Units) Analysis 2015-2019 and Forecast, 2020-2030 7.1. Historical Market Volume (Units) Analysis, 2015-2019 7.2. Current and Future Market Volume (Units) Projections, 2020-2030 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Ophthalmic Eye Drops Market Pricing Analysis 8.1. Regional Pricing Analysis By Product Type 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Ophthalmic Eye Drops Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030 9.1. Historical Market Value (US$ Mn) Analysis, 2015-2019 9.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030, by Drug Class 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2015-2019 10.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Drug Class , 2020-2030 10.3.1. Anaesthetic Drops 10.3.2. Dilation Drops 10.3.3. Glaucoma Drops 10.3.4. Steroid Drops 10.3.5. Antibiotic Drops 10.4. Market Attractiveness Analysis By Drug Class 11. Global Ophthalmic Eye Drops Market Analysis 2015-2019 and Forecast 2020-2030, by Drug Formulation 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) & Volume Analysis By Drug Formulation, 2015-2019 11.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Drug Formulation, 2020-2030 11.3.1. With Preservative 11.3.2. Preservative Free 11.4. Market Attractiveness Analysis By Drug Formulation 12. Global Ophthalmic Eye Drops Market Analysis 2015-2019 and Forecast 2020-2030, by Indication 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015-2019 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2020-2030 12.3.1. Dry Eye 12.3.2. Eye Allergy 12.3.3. Glaucoma 12.3.4. Eye Infection 12.3.5. Retinal Disorders 12.3.5.1. Macular Degeneration 12.3.5.2. Diabetic Retinopathy 12.3.5.3. Others 12.3.6. Uveitis 12.3.7. Others 12.4. Market Attractiveness Analysis By Indication 13. Global Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030, by Container Type 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) & Volume Analysis By Dosage Container, 2015-2019 13.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Container Type, 2020-2030 13.3.1. Single Dose Containers 13.3.2. Multiple-Dose Containers 13.4. Market Attractiveness Analysis By Container Type 14. Global Ophthalmic Eye Drops Market Analysis 2015-2019 and Forecast 2020-2030, by Distribution Channel 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) & Volume Analysis By Distribution Channel, 2015-2019 14.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Distribution Channel, 2020-2030 14.3.1. Institutional Sales 14.3.1.1. Hospitals 14.3.1.2. Community Clinics 14.3.1.3. Ophthalmic Clinics 14.3.1.4. Public Health Agencies 14.3.1.5. Veterinary Hospitals & Clinics 14.3.2. Retail Sales 14.3.2.1. Retail Pharmacies 14.3.2.2. Drug Stores 14.3.2.3. Mail Order Pharmacy 14.4. Market Attractiveness Analysis By Distribution Channel 15. Global Ophthalmic Eye Drops Market Analysis 2015-2019 and Forecast 2020-2030, by Region 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2019 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030 15.3.1. North America 15.3.2. Latin America 15.3.3. Europe 15.3.4. South Asia 15.3.5. East Asia 15.3.6. Oceania 15.3.7. MEA 15.4. Market Attractiveness Analysis By Region 16. North America Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030 16.1. Introduction 16.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Market Taxonomy, 2015-2019 16.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Market Taxonomy, 2020-2030 16.3.1. By Country 16.3.1.1. U.S. 16.3.1.2. Canada 16.3.2. By Drug Class 16.3.3. By Drug Formulation 16.3.4. By Indication 16.3.5. By Container Type 16.3.6. By Distribution Channel 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. Latin America Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030 17.1. Introduction 17.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Market Taxonomy, 2015-2019 17.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Market Taxonomy, 2020-2030 17.3.1. By Country 17.3.1.1. Brazil 17.3.1.2. Mexico 17.3.1.3. Argentina 17.3.1.4. Rest of Latin America 17.3.2. By Drug Class 17.3.3. By Drug Formulation 17.3.4. By Indication 17.3.5. By Container Type 17.3.6. By Distribution Channel 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Europe Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030 18.1. Introduction 18.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Market Taxonomy, 2015-2019 18.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Market Taxonomy, 2020-2030 18.3.1. By Country 18.3.1.1. U.K. 18.3.1.2. Germany 18.3.1.3. Italy 18.3.1.4. Spain 18.3.1.5. France 18.3.1.6. Russia 18.3.1.7. Benelux 18.3.1.8. Rest of Europe 18.3.2. By Drug Class 18.3.3. By Drug Formulation 18.3.4. By Indication 18.3.5. By Container Type 18.3.6. By Distribution Channel 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. South Asia Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030 19.1. Introduction 19.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Market Taxonomy, 2015-2019 19.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Market Taxonomy, 2020-2030 19.3.1. By Country 19.3.1.1. India 19.3.1.2. Thailand 19.3.1.3. Indonesia 19.3.1.4. Malaysia 19.3.1.5. Rest of South Asia 19.3.2. By Drug Class 19.3.3. By Drug Formulation 19.3.4. By Indication 19.3.5. By Container Type 19.3.6. By Distribution Channel 19.4. Market Attractiveness Analysis 19.5. Key Market Participants - Intensity Mapping 19.6. Drivers and Restraints - Impact Analysis 20. East Asia Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030 20.1. Introduction 20.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Market Taxonomy, 2015-2019 20.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Market Taxonomy, 2020-2030 20.3.1. By Country 20.3.1.1. China 20.3.1.2. Japan 20.3.1.3. South Korea 20.3.2. By Drug Class 20.3.3. By Drug Formulation 20.3.4. By Indication 20.3.5. By Container Type 20.3.6. By Distribution Channel 20.4. Market Attractiveness Analysis 20.5. Key Market Participants - Intensity Mapping 20.6. Drivers and Restraints - Impact Analysis 21. Oceania Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030 21.1. Introduction 21.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Market Taxonomy, 2015-2019 21.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Market Taxonomy, 2020-2030 21.3.1. By Country 21.3.1.1. Australia 21.3.1.2. New Zealand 21.3.2. By Drug Class 21.3.3. By Drug Formulation 21.3.4. By Indication 21.3.5. By Container Type 21.3.6. By Distribution Channel 21.4. Market Attractiveness Analysis 21.5. Key Market Participants - Intensity Mapping 21.6. Drivers and Restraints - Impact Analysis 22. MEA Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030 22.1. Introduction 22.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Market Taxonomy, 2015-2019 22.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Market Taxonomy, 2020-2030 22.3.1. By Country 22.3.1.1. GCC 22.3.1.2. South Africa 22.3.1.3. Turkey 22.3.1.4. Rest of MEA 22.3.2. By Drug Class 22.3.3. By Drug Formulation 22.3.4. By Indication 22.3.5. By Container Type 22.3.6. By Distribution Channel 22.4. Market Attractiveness Analysis 22.5. Key Market Participants - Intensity Mapping 22.6. Drivers and Restraints - Impact Analysis 23. Key and Emerging Countries Ophthalmic Eye Drops Market Analysis 2015-2019 and Forecast 2020-2030 23.1. Introduction 23.1.1. Market Value Proportion Analysis, By Key Countries 23.1.2. Global Vs. Country Growth Comparison 23.2. U.S. Ophthalmic Eye Drops Market Analysis 23.2.1. By Drug Class 23.2.2. By Drug Formulation 23.2.3. By Indication 23.2.4. By Container Type 23.2.5. By Distribution Channel 23.3. Canada Ophthalmic Eye Drops Market Analysis 23.3.1. By Drug Class 23.3.2. By Drug Formulation 23.3.3. By Indication 23.3.4. By Container Type 23.3.5. By Distribution Channel 23.4. Brazil Ophthalmic Eye Drops Market Analysis 23.4.1. By Drug Class 23.4.2. By Drug Formulation 23.4.3. By Indication 23.4.4. By Container Type 23.4.5. By Distribution Channel 23.5. Mexico Ophthalmic Eye Drops Market Analysis 23.5.1. By Drug Class 23.5.2. By Drug Formulation 23.5.3. By Indication 23.5.4. By Container Type 23.5.5. By Distribution Channel 23.6. Argentina Ophthalmic Eye Drops Market Analysis 23.6.1. By Drug Class 23.6.2. By Drug Formulation 23.6.3. By Indication 23.6.4. By Container Type 23.6.5. By Distribution Channel 23.7. U.K. Ophthalmic Eye Drops Market Analysis 23.7.1. By Drug Class 23.7.2. By Drug Formulation 23.7.3. By Indication 23.7.4. By Container Type 23.7.5. By Distribution Channel 23.8. Germany Ophthalmic Eye Drops Market Analysis 23.8.1. By Drug Class 23.8.2. By Drug Formulation 23.8.3. By Indication 23.8.4. By Container Type 23.8.5. By Distribution Channel 23.9. Italy Ophthalmic Eye Drops Market Analysis 23.9.1. By Drug Class 23.9.2. By Drug Formulation 23.9.3. By Indication 23.9.4. By Container Type 23.9.5. By Distribution Channel 23.10. France Ophthalmic Eye Drops Market Analysis 23.10.1. By Drug Class 23.10.2. By Drug Formulation 23.10.3. By Indication 23.10.4. By Container Type 23.10.5. By Distribution Channel 23.11. Spain Ophthalmic Eye Drops Market Analysis 23.11.1. By Drug Class 23.11.2. By Drug Formulation 23.11.3. By Indication 23.11.4. By Container Type 23.11.5. By Distribution Channel 23.12. Russia Ophthalmic Eye Drops Market Analysis 23.12.1. By Drug Class 23.12.2. By Drug Formulation 23.12.3. By Indication 23.12.4. By Container Type 23.12.5. By Distribution Channel 23.13. Benelux Ophthalmic Eye Drops Market Analysis 23.13.1. By Drug Class 23.13.2. By Drug Formulation 23.13.3. By Indication 23.13.4. By Container Type 23.13.5. By Distribution Channel 23.14. China Ophthalmic Eye Drops Market Analysis 23.14.1. By Drug Class 23.14.2. By Drug Formulation 23.14.3. By Indication 23.14.4. By Container Type 23.14.5. By Distribution Channel 23.15. Japan Ophthalmic Eye Drops Market Analysis 23.15.1. By Drug Class 23.15.2. By Drug Formulation 23.15.3. By Indication 23.15.4. By Container Type 23.15.5. By Distribution Channel 23.16. South Korea Ophthalmic Eye Drops Market Analysis 23.16.1. By Drug Class 23.16.2. By Drug Formulation 23.16.3. By Indication 23.16.4. By Container Type 23.16.5. By Distribution Channel 23.17. India Ophthalmic Eye Drops Market Analysis 23.17.1. By Drug Class 23.17.2. By Drug Formulation 23.17.3. By Indication 23.17.4. By Container Type 23.17.5. By Distribution Channel 23.18. Indonesia Ophthalmic Eye Drops Market Analysis 23.18.1. By Drug Class 23.18.2. By Drug Formulation 23.18.3. By Indication 23.18.4. By Container Type 23.18.5. By Distribution Channel 23.19. Malaysia Ophthalmic Eye Drops Market Analysis 23.19.1. By Drug Class 23.19.2. By Drug Formulation 23.19.3. By Indication 23.19.4. By Container Type 23.19.5. By Distribution Channel 23.20. ASEAN Ophthalmic Eye Drops Market Analysis 23.20.1. By Drug Class 23.20.2. By Drug Formulation 23.20.3. By Indication 23.20.4. By Distribution Channel 23.21. Australia Ophthalmic Eye Drops Market Analysis 23.21.1. By Drug Class 23.21.2. By Drug Formulation 23.21.3. By Indication 23.21.4. By Container Type 23.21.5. By Distribution Channel 23.22. New Zealand Ophthalmic Eye Drops Market Analysis 23.22.1. By Drug Class 23.22.2. By Drug Formulation 23.22.3. By Indication 23.22.4. By Container Type 23.22.5. By Distribution Channel 23.23. GCC Ophthalmic Eye Drops Market Analysis 23.23.1. By Drug Class 23.23.2. By Drug Formulation 23.23.3. By Indication 23.23.4. By Container Type 23.23.5. By Distribution Channel 23.24. South Africa Ophthalmic Eye Drops Market Analysis 23.24.1. By Drug Class 23.24.2. By Drug Formulation 23.24.3. By Indication 23.24.4. By Container Type 23.24.5. By Distribution Channel 23.25. Turkey Ophthalmic Eye Drops Market Analysis 23.25.1. By Drug Class 23.25.2. By Drug Formulation 23.25.3. By Indication 23.25.4. By Container Type 23.25.5. By Distribution Channel 24. Market Structure Analysis 24.1. Market Analysis by Tier of Companies 24.2. Market Share Analysis of Top Players, By Drug Formulators 24.3. Market Share Analysis of Top Players, By Delivery Systems Manufacturers 24.4. Market Concentration 24.5. Market Presence Analysis 25. Competition Landscape 25.1. Competition Dashboard 25.2. Competition Deep Dive 25.2.1. Finished Product Manufacturers 25.2.1.1. Novartis 25.2.1.1.1. Company Overview 25.2.1.1.2. Product Portfolio 25.2.1.1.3. Sales Footprint 25.2.1.1.4. Strategy Overview 25.2.1.2. Bausch & Lomb 25.2.1.2.1. Company Overview 25.2.1.2.2. Product Portfolio 25.2.1.2.3. Sales Footprint 25.2.1.2.4. Strategy Overview 25.2.1.3. Akorn, Inc. 25.2.1.3.1. Company Overview 25.2.1.3.2. Product Portfolio 25.2.1.3.3. Sales Footprint 25.2.1.3.4. Strategy Overview 25.2.1.4. Biomedica 25.2.1.4.1. Company Overview 25.2.1.4.2. Product Portfolio 25.2.1.4.3. Sales Footprint 25.2.1.4.4. Strategy Overview 25.2.1.5. AdvaCare Pharma 25.2.1.5.1. Company Overview 25.2.1.5.2. Product Portfolio 25.2.1.5.3. Sales Footprint 25.2.1.5.4. Strategy Overview 25.2.1.6. C2 PHARMA 25.2.1.6.1. Company Overview 25.2.1.6.2. Product Portfolio 25.2.1.6.3. Sales Footprint 25.2.1.6.4. Strategy Overview 25.2.1.7. Kraeber GmbH 25.2.1.7.1. Company Overview 25.2.1.7.2. Product Portfolio 25.2.1.7.3. Sales Footprint 25.2.1.7.4. Strategy Overview 25.2.1.8. Iskon Remedies 25.2.1.8.1. Company Overview 25.2.1.8.2. Product Portfolio 25.2.1.8.3. Sales Footprint 25.2.1.8.4. Strategy Overview 25.2.2. OEM 25.2.2.1. HANSHIN GROUP 25.2.2.1.1. Company Overview 25.2.2.1.2. Product Portfolio 25.2.2.1.3. Sales Footprint 25.2.2.1.4. Strategy Overview 25.2.2.2. Berry Global Inc. 25.2.2.2.1. Company Overview 25.2.2.2.2. Product Portfolio 25.2.2.2.3. Sales Footprint 25.2.2.2.4. Strategy Overview 25.2.2.3. Nolato AB 25.2.2.3.1. Company Overview 25.2.2.3.2. Product Portfolio 25.2.2.3.3. Sales Footprint 25.2.2.3.4. Strategy Overview 25.2.2.4. Bormioli Pharma 25.2.2.4.1. Company Overview 25.2.2.4.2. Product Portfolio 25.2.2.4.3. Sales Footprint 25.2.2.4.4. Strategy Overview 25.2.2.5. WG Pro-Manufacturing Inc. 25.2.2.5.1. Company Overview 25.2.2.5.2. Product Portfolio 25.2.2.5.3. Sales Footprint 25.2.2.5.4. Strategy Overview 25.2.2.6. GerresheimerAG 25.2.2.6.1. Company Overview 25.2.2.6.2. Product Portfolio 25.2.2.6.3. Sales Footprint 25.2.2.6.4. Strategy Overview 25.2.2.7. Adelphi Healthcare Packaging 25.2.2.7.1. Company Overview 25.2.2.7.2. Product Portfolio 25.2.2.7.3. Sales Footprint 25.2.2.7.4. Strategy Overview 25.2.2.8. Aptar Group Inc. 25.2.2.8.1. Company Overview 25.2.2.8.2. Product Portfolio 25.2.2.8.3. Sales Footprint 25.2.2.8.4. Strategy Overview 25.2.2.9. Amcor Plc 25.2.2.9.1. Company Overview 25.2.2.9.2. Product Portfolio 25.2.2.9.3. Sales Footprint 25.2.2.9.4. Strategy Overview 26. Assumptions and Acronyms Used 27. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class Table 02: Global Ophthalmic Eye Drops Market Volume (in Mn Units) Analysis and Forecast 2015–2030, By Drug Class Table 03: Global Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Formulation Table 04: Global Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication Table 05: Global Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Container Type Table 06: Global Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel Table 07: Global Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region Table 08: Global Ophthalmic Eye Drops Market Volume (in Mn Units) Analysis and Opportunity Assessment 2015–2030, By Region Table 09: North America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country Table 10: North America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class Table 11: North America Ophthalmic Eye Drops Market Volume (Mn Units) Analysis and Opportunity Assessment 2015–2030, By Drug Class Table 12: North America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication Table 13: North America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Formulation Table 14: North America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Container Type Table 15: North America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel Table 16: Latin America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country Table 17: Latin America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class Table 18: Latin America Ophthalmic Eye Drops Market Volume (Mn Units) Analysis and Opportunity Assessment 2015–2030, By Drug Class Table 19: Latin America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication Table 20: Latin America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Formulation Table 21: Latin America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Container Type Table 22: Latin America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel Table 23: Europe Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country Table 24: Europe Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class Table 25: Europe Ophthalmic Eye Drops Market Volume (Mn Units) Analysis and Opportunity Assessment 2015–2030, By Drug Class Table 26: Europe Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication Table 27: Europe Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Formulation Table 28: Europe Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Container Type Table 29: Europe Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel Table 30: South Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country Table 31: South Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class Table 32: South Asia Ophthalmic Eye Drops Market Volume (Mn Units) Analysis and Opportunity Assessment 2015–2030, By Drug Class Table 33: South Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication Table 34: South Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Formulation Table 35: South Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Container Type Table 36: South Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel Table 37: East Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country Table 38: East Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class Table 39: East Asia Ophthalmic Eye Drops Market Volume (Mn Units) Analysis and Opportunity Assessment 2015–2030, By Drug Class Table 40: East Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication Table 41: East Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Formulation Table 42: East Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Container Type Table 43: East Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel Table 44: Oceania Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country Table 45: Oceania Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class Table 46: Oceania Ophthalmic Eye Drops Market Volume (Mn Units) Analysis and Opportunity Assessment 2015–2030, By Drug Class Table 47: Oceania Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication Table 48: Oceania Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Formulation Table 49: Oceania Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Container Type Table 50: Oceania Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel Table 51: MEA Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country Table 52: MEA Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class Table 53: MEA Ophthalmic Eye Drops Market Volume (Mn Units) Analysis and Opportunity Assessment 2015–2030, By Drug Class Table 54: MEA Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication Table 55: MEA Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Formulation Table 56: MEA Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Container Type Table 57: MEA Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Ophthalmic Eye Drops Market Volume Analysis (Mn Units), 2015-2019 Figure 02: Global Ophthalmic Eye Drops Market Volume Forecast (Mn Units), 2020-2030 Figure 03: Global Ophthalmic Eye Drops Market Value Analysis (US$ Mn), 2015-2019 Figure 04: Global Ophthalmic Eye Drops Market Value Forecast (US$ Mn), 2020-2030 Figure 05: Global Ophthalmic Eye Drops Market Absolute $ Opportunity, 2020 - 2030 Figure 06: Global Ophthalmic Eye Drops Market Share Analysis (%), By Drug Class, 2020-2030 Figure 07: Global Ophthalmic Eye Drops Market Y-o-Y Analysis (%), By Drug Class, 2020-2030 Figure 08: Global Ophthalmic Eye Drops Market Attractiveness Analysis by Drug Class, 2020-2030 Figure 09: Global Ophthalmic Eye Drops Market Share Analysis (%), By Drug Formulation, 2020-2030 Figure 10: Global Ophthalmic Eye Drops Market Y-o-Y Analysis (%), By Drug Formulation, 2020-2030 Figure 11: Global Ophthalmic Eye Drops Market Attractiveness Analysis By Drug Formulation, 2020-2030 Figure 12: Global Ophthalmic Eye Drops Market Share Analysis (%), By Indication, 2020-2030 Figure 13: Global Ophthalmic Eye Drops Market Y-o-Y Analysis (%), By Indication, 2020-2030 Figure 14: Global Ophthalmic Eye Drops Market Attractiveness Analysis By Indication, 2020-2030 Figure 15: Global Ophthalmic Eye Drops Market Share Analysis (%), By Container Type, 2020-2030 Figure 16: Global Ophthalmic Eye Drops Market Y-o-Y Analysis (%), By Container Type, 2020-2030 Figure 17: Global Ophthalmic Eye Drops Market Attractiveness Analysis By Container Type, 2020-2030 Figure 18: Global Ophthalmic Eye Drops Market Share Analysis (%), By Distribution Channel, 2020-2030 Figure 19: Global Ophthalmic Eye Drops Market Y-o-Y Analysis (%), By Distribution Channel, 2020-2030 Figure 20: Global Ophthalmic Eye Drops Market Attractiveness Analysis by Distribution Channel, 2020-2030 Figure 21: Global Ophthalmic Eye Drops Market Share Analysis (%), By Region, 2020-2030 Figure 22: Global Ophthalmic Eye Drops Market Y-o-Y Analysis (%), By Region, 2020-2030 Figure 23: Global Ophthalmic Eye Drops Market Attractiveness Analysis by Region, 2020-2030 Figure 24: North America Ophthalmic Eye Drops Market Value Share, By Drug Class, 2020 (E) Figure 25: North America Ophthalmic Eye Drops Market Value Share, By Indication, 2020 (E) Figure 26: North America Ophthalmic Eye Drops Market Value Share, By Drug Formulation, 2020 (E) Figure 27: North America Ophthalmic Eye Drops Market Value Share, By Container Type, 2020 (E) Figure 28: North America Ophthalmic Eye Drops Market Value Share, By Distribution Channel, 2020 (E) Figure 29: North America Ophthalmic Eye Drops Market Value Share, By Country, 2020 (E) Figure 30: North America Ophthalmic Eye Drops Market Value Analysis (US$ Mn), 2015-2019 Figure 31: North America Ophthalmic Eye Drops Market Value Forecast (US$ Mn), 2020-2030 Figure 32: North America Ophthalmic Eye Drops Market Attractiveness Analysis by Drug Class, 2020-2030 Figure 33: North America Ophthalmic Eye Drops Market Attractiveness Analysis By Indication, 2020-2030 Figure 34: North America Ophthalmic Eye Drops Market Attractiveness Analysis By Drug Formulation, 2020-2030 Figure 35: North America Ophthalmic Eye Drops Market Attractiveness Analysis By Container Type, 2020-2030 Figure 36: North America Ophthalmic Eye Drops Market Attractiveness Analysis by Distribution Channel, 2020-2030 Figure 37: North America Ophthalmic Eye Drops Market Attractiveness Analysis by Country, 2020-2030 Figure 38: Latin America Ophthalmic Eye Drops Market Value Share, By Drug Class, 2020 (E) Figure 39: Latin America Ophthalmic Eye Drops Market Value Share, By Indication, 2020 (E) Figure 40: Latin America Ophthalmic Eye Drops Market Value Share, By Drug Formulation, 2020 (E) Figure 41: Latin America Ophthalmic Eye Drops Market Value Share, By Container Type, 2020 (E) Figure 42: Latin America Ophthalmic Eye Drops Market Value Share, By Distribution Channel, 2020 (E) Figure 43: Latin America Ophthalmic Eye Drops Market Value Share, By Country, 2020 (E) Figure 44: Latin America Ophthalmic Eye Drops Market Value Analysis (US$ Mn), 2015-2019 Figure 45: Latin America Ophthalmic Eye Drops Market Value Forecast (US$ Mn), 2020-2030 Figure 46: Latin America Ophthalmic Eye Drops Market Attractiveness Analysis by Drug Class, 2020-2030 Figure 47: Latin America Ophthalmic Eye Drops Market Attractiveness Analysis By Indication, 2020-2030 Figure 48: Latin America Ophthalmic Eye Drops Market Attractiveness Analysis By Drug Formulation, 2020-2030 Figure 49: Latin America Ophthalmic Eye Drops Market Attractiveness Analysis By Container Type, 2020-2030 Figure 50: Latin America Ophthalmic Eye Drops Market Attractiveness Analysis by Distribution Channel, 2020-2030 Figure 51: Latin America Ophthalmic Eye Drops Market Attractiveness Analysis by Country, 2020-2030 Figure 52: Europe Ophthalmic Eye Drops Market Value Share, By Drug Class, 2020 (E) Figure 53: Europe Ophthalmic Eye Drops Market Value Share, By Indication, 2020 (E) Figure 54: Europe Ophthalmic Eye Drops Market Value Share, By Drug Formulation, 2020 (E) Figure 55: Europe Ophthalmic Eye Drops Market Value Share, By Container Type, 2020 (E) Figure 56: Europe Ophthalmic Eye Drops Market Value Share, By Distribution Channel, 2020 (E) Figure 57: Europe Ophthalmic Eye Drops Market Value Share, By Country, 2020 (E) Figure 58: Europe Ophthalmic Eye Drops Market Value Analysis (US$ Mn), 2015-2019 Figure 59: Europe Ophthalmic Eye Drops Market Value Forecast (US$ Mn), 2020-2030 Figure 60: Europe Ophthalmic Eye Drops Market Attractiveness Analysis by Drug Class, 2020-2030 Figure 61: Europe Ophthalmic Eye Drops Market Attractiveness Analysis By Indication, 2020-2030 Figure 62: Europe Ophthalmic Eye Drops Market Attractiveness Analysis By Drug Formulation, 2020-2030 Figure 63: Europe Ophthalmic Eye Drops Market Attractiveness Analysis By Container Type, 2020-2030 Figure 64: Europe Ophthalmic Eye Drops Market Attractiveness Analysis by Distribution Channel, 2020-2030 Figure 65: Europe Ophthalmic Eye Drops Market Attractiveness Analysis by Country, 2020-2030 Figure 66: South Asia Ophthalmic Eye Drops Market Value Share, By Drug Class, 2020 (E) Figure 67: South Asia Ophthalmic Eye Drops Market Value Share, By Indication, 2020 (E) Figure 68: South Asia Ophthalmic Eye Drops Market Value Share, By Drug Formulation, 2020 (E) Figure 69: South Asia Ophthalmic Eye Drops Market Value Share, By Container Type, 2020 (E) Figure 70: South Asia Ophthalmic Eye Drops Market Value Share, By Distribution Channel, 2020 (E) Figure 71: South Asia Ophthalmic Eye Drops Market Value Share, By Country, 2020 (E) Figure 72: South Asia Ophthalmic Eye Drops Market Value Analysis (US$ Mn), 2015-2019 Figure 73: South Asia Ophthalmic Eye Drops Market Value Forecast (US$ Mn), 2020-2030 Figure 74: South Asia Ophthalmic Eye Drops Market Attractiveness Analysis by Drug Class, 2020-2030 Figure 75: South Asia Ophthalmic Eye Drops Market Attractiveness Analysis By Indication, 2020-2030 Figure 76: South Asia Ophthalmic Eye Drops Market Attractiveness Analysis By Drug Formulation, 2020-2030 Figure 77: South Asia Ophthalmic Eye Drops Market Attractiveness Analysis By Container Type, 2020-2030 Figure 78: South Asia Ophthalmic Eye Drops Market Attractiveness Analysis by Distribution Channel, 2020-2030 Figure 79: South Asia Ophthalmic Eye Drops Market Attractiveness Analysis by Country, 2020-2030 Figure 80: East Asia Ophthalmic Eye Drops Market Value Share, By Drug Class, 2020 (E) Figure 81: East Asia Ophthalmic Eye Drops Market Value Share, By Indication, 2020 (E) Figure 82: East Asia Ophthalmic Eye Drops Market Value Share, By Drug Formulation, 2020 (E) Figure 83: East Asia Ophthalmic Eye Drops Market Value Share, By Container Type, 2020 (E) Figure 84: East Asia Ophthalmic Eye Drops Market Value Share, By Distribution Channel, 2020 (E) Figure 85: East Asia Ophthalmic Eye Drops Market Value Share, By Country, 2020 (E) Figure 86: East Asia Ophthalmic Eye Drops Market Value Analysis (US$ Mn), 2015-2019 Figure 87: East Asia Ophthalmic Eye Drops Market Value Forecast (US$ Mn), 2020-2030 Figure 88: East Asia Ophthalmic Eye Drops Market Attractiveness Analysis by Drug Class, 2020-2030 Figure 89: East Asia Ophthalmic Eye Drops Market Attractiveness Analysis By Indication, 2020-2030 Figure 90: East Asia Ophthalmic Eye Drops Market Attractiveness Analysis By Drug Formulation, 2020-2030 Figure 91: East Asia Ophthalmic Eye Drops Market Attractiveness Analysis By Container Type, 2020-2030 Figure 92: East Asia Ophthalmic Eye Drops Market Attractiveness Analysis by Distribution Channel, 2020-2030 Figure 93: East Asia Ophthalmic Eye Drops Market Attractiveness Analysis by Country, 2020-2030 Figure 94: Oceania Ophthalmic Eye Drops Market Value Share, By Drug Class, 2020 (E) Figure 95: Oceania Ophthalmic Eye Drops Market Value Share, By Indication, 2020 (E) Figure 96: Oceania Ophthalmic Eye Drops Market Value Share, By Drug Formulation, 2020 (E) Figure 97: Oceania Ophthalmic Eye Drops Market Value Share, By Container Type, 2020 (E) Figure 98: Oceania Ophthalmic Eye Drops Market Value Share, By Distribution Channel, 2020 (E) Figure 99: Oceania Ophthalmic Eye Drops Market Value Share, By Country, 2020 (E) Figure 100: Oceania Ophthalmic Eye Drops Market Value Analysis (US$ Mn), 2015-2019 Figure 101: Oceania Ophthalmic Eye Drops Market Value Forecast (US$ Mn), 2020-2030 Figure 102: Oceania Ophthalmic Eye Drops Market Attractiveness Analysis by Drug Class, 2020-2030 Figure 103: Oceania Ophthalmic Eye Drops Market Attractiveness Analysis By Indication, 2020-2030 Figure 104: Oceania Ophthalmic Eye Drops Market Attractiveness Analysis By Drug Formulation, 2020-2030 Figure 105: Oceania Ophthalmic Eye Drops Market Attractiveness Analysis By Container Type, 2020-2030 Figure 106: Oceania Ophthalmic Eye Drops Market Attractiveness Analysis by Distribution Channel, 2020-2030 Figure 107: Oceania Ophthalmic Eye Drops Market Attractiveness Analysis by Country, 2020-2030 Figure 108: MEA Ophthalmic Eye Drops Market Value Share, By Drug Class, 2020 (E) Figure 109: MEA Ophthalmic Eye Drops Market Value Share, By Indication, 2020 (E) Figure 110: MEA Ophthalmic Eye Drops Market Value Share, By Drug Formulation, 2020 (E) Figure 111: MEA Ophthalmic Eye Drops Market Value Share, By Container Type, 2020 (E) Figure 112: MEA Ophthalmic Eye Drops Market Value Share, By Distribution Channel, 2020 (E) Figure 113: MEA Ophthalmic Eye Drops Market Value Share, By Country, 2020 (E) Figure 114: MEA Ophthalmic Eye Drops Market Value Analysis (US$ Mn), 2015-2019 Figure 115: MEA Ophthalmic Eye Drops Market Value Forecast (US$ Mn), 2020-2030 Figure 116: MEA Ophthalmic Eye Drops Market Attractiveness Analysis by Drug Class, 2020-2030 Figure 117: MEA Ophthalmic Eye Drops Market Attractiveness Analysis By Indication, 2020-2030 Figure 118: MEA Ophthalmic Eye Drops Market Attractiveness Analysis By Drug Formulation, 2020-2030 Figure 119: MEA Ophthalmic Eye Drops Market Attractiveness Analysis By Container Type, 2020-2030 Figure 120: MEA Ophthalmic Eye Drops Market Attractiveness Analysis by Distribution Channel, 2020-2030 Figure 121: MEA Ophthalmic Eye Drops Market Attractiveness Analysis by Country, 2020-2030 Figure 122: U.S. Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 123: U.S. Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 124: U.S. Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 125: U.S. Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 126: U.S. Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 127: Global Vs. U.S. Growth Comparison Figure 128: Canada Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 129: Canada Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 130: Canada Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 131: Canada Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 132: Canada Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 133: Global Vs. Canada Growth Comparison Figure 134: Brazil Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 135: Brazil Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 136: Brazil Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 137: Brazil Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 138: Brazil Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 139: Global Vs. Brazil Growth Comparison Figure 140: Mexico Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 141: Mexico Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 142: Mexico Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 143: Mexico Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 144: Mexico Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 145: Global Vs. Mexico Growth Comparison Figure 146: Argentina Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 147: Argentina Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 148: Argentina Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 149: Argentina Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 150: Argentina Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 151: Global Vs. Argentina Growth Comparison Figure 152: U.K. Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 153: U.K. Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 154: U.K. Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 155: U.K. Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 156: U.K. Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 157: Global Vs. U.K. Growth Comparison Figure 158: Germany Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 159: Germany Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 160: Germany Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 161: Germany Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 162: Germany Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 163: Global Vs. Germany Growth Comparison Figure 164: Italy Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 165: Italy Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 166: Italy Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 167: Italy Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 168: Italy Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 169: Global Vs. Italy Growth Comparison Figure 170: France Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 171: France Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 172: France Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 173: France Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 174: France Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 175: Global Vs. France Growth Comparison Figure 176: Spain Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 177: Spain Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 178: Spain Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 179: Spain Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 180: Spain Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 181: Global Vs. Spain Growth Comparison Figure 182: Russia Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 183: Russia Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 184: Russia Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 185: Russia Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 186: Russia Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 187: Global Vs. Russia Growth Comparison Figure 188: China Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 189: China Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 190: China Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 191: China Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 192: China Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 193: Global Vs. China Growth Comparison Figure 194: Japan Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 195: Japan Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 196: Japan Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 197: Japan Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 198: Japan Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 199: Global Vs. Japan Growth Comparison Figure 200: South Korea Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 201: South Korea Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 202: South Korea Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 203: South Korea Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 204: South Korea Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 205: Global Vs. South Korea Growth Comparison Figure 206: India Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 207: India Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 208: India Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 209: India Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 210: India Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 211: Global Vs. India Growth Comparison Figure 212: Indonesia Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 213: Indonesia Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 214: Indonesia Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 215: Indonesia Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 216: Indonesia Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 217: Global Vs. Indonesia Growth Comparison Figure 218: Malaysia Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 219: Malaysia Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 220: Malaysia Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 221: Malaysia Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 222: Malaysia Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 223: Global Vs. Malaysia Growth Comparison Figure 224: Thailand Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 225: Thailand Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 226: Thailand Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 227: Thailand Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 228: Thailand Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 229: Global Vs. Thailand Growth Comparison Figure 230: Australia Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 231: Australia Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 232: Australia Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 233: Australia Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 234: Australia Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 235: Global Vs. Australia Growth Comparison Figure 236: New Zealand Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 237: New Zealand Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 238: New Zealand Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 239: New Zealand Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 240: New Zealand Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 241: Global Vs. New Zealand Growth Comparison Figure 242: GCC Countries Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 243: GCC Countries Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 244: GCC Countries Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 245: GCC Countries Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 246: GCC Countries Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 247: Global Vs. GCC Countries Growth Comparison Figure 248: South Africa Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 249: South Africa Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 250: South Africa Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 251: South Africa Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 252: South Africa Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 253: Global Vs. South Africa Growth Comparison Figure 254: Turkey Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030 Figure 255: Turkey Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030 Figure 256: Turkey Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030 Figure 257: Turkey Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030 Figure 258: Turkey Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030 Figure 259: Global Vs. Turkey Growth Comparison
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
